William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 16,300 shares at $113.18 ($1.8M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($1.8M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.18 | 11,530 | $1.3M | 70.6% |
| 2 | $114.04 | 4,770 | $544K | 29.4% |
| Total | $113.43 avg | 16,300 | $1.8M | 100% |
| Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |
| CORT | SELL | 2026-03-24 | $424K | — | Filing → |